Dr Reddys Laboratories (RDY) Enterprise Value: 2017-2025
Historic Enterprise Value for Dr Reddys Laboratories (RDY) over the last 2 years, with Mar 2025 value amounting to $10.3 billion.
- Dr Reddys Laboratories' Enterprise Value fell 8.13% to $10.3 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $8.0 billion, marking a year-over-year decrease of 15.04%. This contributed to the annual value of $10.3 billion for FY2025, which is 8.13% down from last year.
- Per Dr Reddys Laboratories' latest filing, its Enterprise Value stood at $10.3 billion for Q1 2025, which was down 8.13% from $11.2 billion recorded in Q1 2024.
- In the past 5 years, Dr Reddys Laboratories' Enterprise Value ranged from a high of $11.2 billion in Q1 2024 and a low of $8.7 billion during Q1 2022.
- Its 3-year average for Enterprise Value is $10.1 billion, with a median of $10.3 billion in 2025.
- Its Enterprise Value has fluctuated over the past 5 years, first spiked by 53.05% in 2021, then declined by 10.75% in 2022.
- Quarterly analysis of 5 years shows Dr Reddys Laboratories' Enterprise Value stood at $9.7 billion in 2021, then dropped by 10.75% to $8.7 billion in 2022, then increased by 0.46% to $8.7 billion in 2023, then grew by 28.84% to $11.2 billion in 2024, then dropped by 8.13% to $10.3 billion in 2025.
- Its Enterprise Value was $10.3 billion in Q1 2025, compared to $11.2 billion in Q1 2024 and $8.7 billion in Q1 2023.